Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway
Author:
Affiliation:
1. Department of Chemistry & Institutes of Biomedical Sciences, Fudan University, Shanghai, China
Funder
National Natural Science Foundation of China
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2210845
Reference94 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2. TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
3. Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
4. Cisplatin in cancer therapy: Molecular mechanisms of action
5. Trastuzumab Deruxtecan: First Approval
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma;Journal of Clinical Investigation;2024-01-16
2. The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?;International Journal of Molecular Sciences;2023-12-29
3. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway;Journal of Translational Medicine;2023-12-06
4. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway;2023-09-13
5. Beyond DNA sensing: expanding the role of cGAS/STING in immunity and diseases;Archives of Pharmacal Research;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3